Clinical Trials · NCT04601740
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in The Netherlands, as Part of Local Clinical Practice
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 145
- Start date
- Nov 2020
- Locations
- 1 site, Netherlands
- Primary endpoint
- Change in Glycated haemoglobin (HbA1c )